The tribulations of community-based trials

January 2004
CMAJ: Canadian Medical Association Journal;1/6/2004, Vol. 170 Issue 1, p33
Academic Journal
Focuses on the trend of clinical trials sponsored by the pharmaceutical industry in Canada migrating from academic settings into the community. Challenges posed to physicians and the medical profession; Impact on issues of conflict of interest, patient safety and public interest; Percentage of clinical trials conducted in Canada in 2002 that were industry sponsored.


Related Articles

  • Working the Pharmaceutical PIPELINE Databases. Breton, Tara // Searcher;Sep2003, Vol. 11 Issue 8, p32 

    Presents information on how to use a pharmaceutical pipeline database. Definition of a pipeline; Levels of a pharmaceutical pipeline; Information on the actual pipeline process.

  • Optimizing Phase III Trials. McLennan, Derek; Foley, Patrick // European Pharmaceutical Executive;Feb/Mar2007, p40 

    The article discusses some of the pitfalls inherent in the Phase III planning process and proposes some solutions for getting it right. The authors suggests that developing successful Phase III clinical trial strategies in today's European pharmaceutical marketing environment requires a balance...

  • Should paediatricians support the European Paediatric Clinical Trials Register? Sammons, H. M.; Naylor, C.; Choonara, I.; Pandolfini, C.; Bonati, M. // Archives of Disease in Childhood;Jun2005, Vol. 90 Issue 6, p559 

    The article discusses the need of pediatricians' support for European Paediatric Clinical Trials Register. A European legislation is currently being proposed that will provide a financial incentive to the pharmaceutical industry to study medicines in Europe. The proposal has been prepared by the...

  • Calendar.  // Pharmaceutical Technology;Oct2004, Vol. 28 Issue 10, p224 

    The article presents information about various meetings related to pharmaceutical industry. "Validation Week-Annual Meeting," will take place in October 2004 in Philadelphia, Pennsylvania. "AAPS: Annual Meeting and Exposition," will take place in November 2004 in Baltimore. "International...

  • Expert offers strategies for survival in today's CR environment.  // Clinical Trials Administrator;Jun2008, Vol. 6 Issue 6, p70 

    The article offers suggestions to clinical trial (CT) investigators and professionals on handling the challenges in the clinical research industry. Investing in training program, as suggested, will likely helped familiarized the staff with the CT site's standard operating procedures. A careful...

  • Attitudes towards clinical research among cancer trial participants and non-participants: an interview study using a Grounded Theory approach. Madsen, S. M.; Holm, S.; Riis, P. // Journal of Medical Ethics;Apr2007, Vol. 33 Issue 4, p234 

    The attitudes of women patients with cancer were explored when they were invited to participate in one of three randomised trials that included chemotherapy at two university centres and a satellite centre. Fourteen patients participating in and 15 patients declining trials were interviewed....

  • Randomized clinical trials: Slow death by a thousand unnecessary policies? Ferris, Lorraine E.; Naylor, C. David // CMAJ: Canadian Medical Association Journal;10/12/2004, Vol. 171 Issue 8, p892 

    Focuses on financial conflicts of interest between researchers and industry sponsors in conducting clinical trials. Roles of researchers in clinical trials; Purpose of pharmaceutical companies in conducting their own clinical trials; Susceptibility of preapproval studies by pharmaceutical...

  • Site Perceptions. Adelglass, Jeffrey // CenterWatch Weekly;2/10/2014, Vol. 18 Issue 6, p7 

    The article presents the author's views on the issues related to the site performance in the clinical trials industry. He says that principal investigators have to keep pace with the increasing demand of business practice improvement for sites. He focuses on the importance of changes in the...

  • Scaled-up self-experimentation proposed. Spinney, Laura // Nature Medicine;May2008, Vol. 14 Issue 5, p471 

    The article reports on the proposal of biotech entrepreneur William Bains that self-experimenters should form collectives to make their findings more acceptable to the scientific community in Great Britain. Bains believed the impact of high costs and red tape in clinical trials on the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics